Flourish Research adds Suncoast Research Group, a multi-therapeutic research site in Little Havana, Miami, to its growing U.S. presence.
NEW YORK, Dec. 22, 2022 /PRNewswire-PRWeb/ -- Flourish Research is pleased to announce the acquisition of Suncoast Research Group. Suncoast is a leading, multi-therapeutic clinical research site based in Miami, Florida.
Founded by Marco Ramirez and Dr. Mark Kutner in 2004, Suncoast has built its reputation as a leading clinical research site through its commitment to patients and biopharma sponsors. Based in Little Havana, the heart of Latin community in Miami, Suncoast focuses on increasing access to and awareness of clinical trials to a diverse population of minority patients. Suncoast's patient-first mentality and focus on patient diversification creates immediate cultural alignment with the existing Flourish platform. Ramirez, Dr. Kutner and the current management team will continue in their roles at Suncoast after the acquisition.
Reinhold Schulz, CEO of Flourish Research, said, "We welcome the Suncoast team, which has forged impressive ties with major sponsors and CROs, thanks to the success of their enrollment and quality. This acquisition will attract new opportunities and continue to bolster Flourish's core therapeutic strengths. I am excited for Suncoast to contribute to Flourish's journey as a national leader in clinical research."
Ramirez, Founder and CEO of Suncoast, said, "We are excited to be a part of Flourish and to join the shared vision of advancing the health of our society through clinical trials. We believe our breadth of therapeutic expertise and access to the diverse patient populations within Miami provides depth of resources and knowledge, ultimately resulting in greater value to our sponsors and patients."
About Flourish Research:
Flourish Research was founded to address the highly fragmented clinical trial site market. By acquiring and fully integrating best-in-class sites, Flourish provides a unique opportunity to serve sponsors and CROs with increased speed and efficiency across a variety of therapeutic areas and indications, while offering a single point of entry to multiple sites. Flourish currently has locations in Florida, Illinois, Pennsylvania, and Texas. For additional information on Flourish, please visit our website at https://flourishresearch.com/
Flourish sites conduct Phase I-IV studies across therapeutic areas where they have deep expertise, including Cardiology/Metabolic Disease/Renal, CNS, Pulmonology, and Vaccines.
Media Contact
Cindi Heckmann, Flourish Research, 1 210-854-1614, [email protected]
SOURCE Flourish Research
Share this article